Ligand Reports First Quarter 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Ligand Reports First Quarter 2021 Financial Results

Ligand Pharma (LGND) Tops Q1 EPS by 29c, Offers FY Guidance

May 3, 2021 4:57 PM EDT

Ligand Pharma (NASDAQ: LGND) reported Q1 EPS of $1.41, $0.29 better than the analyst estimate of $1.12. Revenue for the quarter came in at $55.2 million versus the consensus estimate of $62.85 million.

GUIDANCE:

Ligand Pharma sees 2021 EPS of $6.15, versus the consensus of $6.17. Ligand Pharma... More